Chi-Med
Maria Ferrara, MBA, LSSGB, is a highly experienced regulatory operations leader with significant expertise in managing global submissions and compliance within the pharmaceutical industry. Currently serving as Senior Director and Head of Regulatory Operations & Submissions at HUTCHMED since April 2020, Maria has successfully established efficient operational frameworks, expanded the functionality of VEEVA RIM systems, and streamlined cross-regional procedures. Previous roles include Associate Director at Bayer Pharmaceuticals, where responsibilities encompassed oversight of global archiving strategies and submission management, as well as a Senior Regulatory Manager at Actavis Pharmaceuticals, focusing on U.S. regulatory requirements in various therapeutic areas. Maria's extensive education includes multiple degrees from Fairleigh Dickinson University, comprising an MBA in Management and an MBA in Management Information Systems.
Chi-Med
Hutchison China MediTech, or Chi-Med, is an innovative biopharmaceutical company which researches, develops, manufactures and sells pharmaceuticals and healthcare products. Its Innovation Platform, Hutchison MediPharma, focuses on discovering and deve...